Key Takeaways from Analyst
Global paracetamol IV market can witness growth over the forecast period, owing to rising prevalence of fever and pain disorders worldwide. Growing geriatric population who are more susceptible to chronic diseases can also boost demand for paracetamol injectables. Furthermore, rapid development of infusion and injection techniques encourages healthcare professionals to prefer IV mode of paracetamol administration over oral dosage forms. North America currently dominates the market but Asia Pacific is expected to emerge as the fastest growing region due to rising healthcare expenditure and increasing awareness.
Availability of alternative drug entities for fever and pain reduction can hamper the market growth. Moreover, stringent regulations pertaining to approval of IV drugs may act as a restraining factor. Increasing demand for fast-acting analgesics in hospital settings can counteract this effect. Manufacturers should focus on Asia Pacific region by strengthening their distribution networks. Contract manufacturing and collaboration with local players can help achieve higher penetration in emerging countries. Providing customizable solutions tailored for diverse geographies would also create opportunities for sustained long-term growth.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients